Organization: Health Canada
Year: 2024
Month: February
Request Number: A-2022-001649
Request Summary: Advise whether this desmopressin Abbreviated New Drug Submission (ANDS), which was accepted into review on or after March 1, 2022, but before December 1, 2022, has: received a Notice of Deficiency (NOD); received a Notice of Non-Compliance (NON); received a NOD-Withdrawal (NOD-W); received a NON-Withdrawal (NON-W); or is on Patent Hold. If this desmopressin ANDS has received any of the notices listed above, or if it was put on Patent Hold, advise of the month and year that the notice/hold was issued; and provide a copy of the correspondence.
Disposition: Disclosed in part
Number of pages: 17